Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

ACHV

Achieve Life Sciences (ACHV)

Achieve Life Sciences Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:ACHV
DatumZeitQuelleÜberschriftSymbolFirma
25/04/202414h00GlobeNewswire Inc.Achieve Life Sciences to Announce First Quarter Financial Results and Host Conference Call and Webcast on May 9, 2024NASDAQ:ACHVAchieve Life Sciences Inc
11/04/202414h00GlobeNewswire Inc.Achieve Life Sciences to Present at Life Science Innovation Northwest 2024 ConferenceNASDAQ:ACHVAchieve Life Sciences Inc
28/03/202421h01GlobeNewswire Inc.Achieve Life Sciences Reports Financial Results for Fourth Quarter and Year-End 2023 and Provides Corporate UpdateNASDAQ:ACHVAchieve Life Sciences Inc
20/03/202413h00GlobeNewswire Inc.Achieve Life Sciences Announces Data from Cytisinicline ORCA Program to be Presented at the 2024 Society for Research on Nicotine and Tobacco (SRNT) Annual MeetingNASDAQ:ACHVAchieve Life Sciences Inc
14/03/202413h00GlobeNewswire Inc.Achieve Life Sciences to Announce Fourth Quarter and Year-End 2023 Financial Results and Host Conference Call and Webcast on March 28, 2024NASDAQ:ACHVAchieve Life Sciences Inc
06/03/202422h49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACHVAchieve Life Sciences Inc
06/03/202422h43Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACHVAchieve Life Sciences Inc
29/02/202422h41Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACHVAchieve Life Sciences Inc
29/02/202422h16Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ACHVAchieve Life Sciences Inc
29/02/202414h01GlobeNewswire Inc.Achieve Life Sciences Reaches Agreement with the FDA on Long-Term Cytisinicline Exposure Data Requirements for NDA SubmissionNASDAQ:ACHVAchieve Life Sciences Inc
29/02/202414h00GlobeNewswire Inc.Achieve Life Sciences Announces Pricing of up to $124.2 Million Registered Direct Offering and Concurrent Private PlacementNASDAQ:ACHVAchieve Life Sciences Inc
27/02/202421h32Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:ACHVAchieve Life Sciences Inc
29/01/202420h07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACHVAchieve Life Sciences Inc
25/01/202401h22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACHVAchieve Life Sciences Inc
25/01/202401h20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACHVAchieve Life Sciences Inc
25/01/202401h09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACHVAchieve Life Sciences Inc
25/01/202401h07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACHVAchieve Life Sciences Inc
25/01/202401h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACHVAchieve Life Sciences Inc
25/01/202401h01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACHVAchieve Life Sciences Inc
25/01/202400h58Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACHVAchieve Life Sciences Inc
25/01/202400h54Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACHVAchieve Life Sciences Inc
11/12/202322h04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACHVAchieve Life Sciences Inc
09/11/202322h08Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ACHVAchieve Life Sciences Inc
09/11/202322h00GlobeNewswire Inc.Achieve Life Sciences Reports Financial Results for Third Quarter and Provides Corporate UpdateNASDAQ:ACHVAchieve Life Sciences Inc
26/10/202314h00GlobeNewswire Inc.Achieve Life Sciences to Announce Third Quarter 2023 Financial Results and Host Conference Call and Webcast on November 9, 2023NASDAQ:ACHVAchieve Life Sciences Inc
03/10/202314h00GlobeNewswire Inc.Achieve Life Sciences Announces Participation at Upcoming Investor ConferencesNASDAQ:ACHVAchieve Life Sciences Inc
11/09/202314h00GlobeNewswire Inc.Achieve Life Sciences Announces Presentation of Cytisinicline E-Cigarette Cessation (ORCA-V1) Results at Society for Research on Nicotine and Tobacco Europe (SRNT-E) Annual MeetingNASDAQ:ACHVAchieve Life Sciences Inc
07/09/202314h00GlobeNewswire Inc.Achieve Life Sciences Announces Participation at Upcoming Investor ConferencesNASDAQ:ACHVAchieve Life Sciences Inc
14/08/202322h09Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ACHVAchieve Life Sciences Inc
14/08/202322h06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACHVAchieve Life Sciences Inc
 Showing the most relevant articles for your search:NASDAQ:ACHV